HIND logo

Vyome Holdings, Inc. Stock Price

NasdaqCM:HIND Community·US$19.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

HIND Share Price Performance

US$3.44
-10.56 (-75.43%)
US$3.44
-10.56 (-75.43%)
Price US$3.44

HIND Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with high growth potential.

3 Risks
2 Rewards

Vyome Holdings, Inc. Key Details

US$344.6k

Revenue

US$85.1k

Cost of Revenue

US$259.5k

Gross Profit

US$9.6m

Other Expenses

-US$9.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-1.66
75.30%
-2,711.36%
0%
View Full Analysis

About HIND

Founded
2017
Employees
18
CEO
Venkateswarlu Nelabhotla
WebsiteView website
www.vyometx.com

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Cambridge, Massachusetts.

Recent HIND News & Updates

Recent updates

No updates